University of North Carolina Hospital 101 Manning Drive, Chapel Hill, NC 27514
Education:
Medical School Duke University Graduated: 1985 Medical School University Of North Carolina Hospitals Graduated: 1985 Medical School University Of Michigan Hospitals Graduated: 1985
University North Carolina Cancer Center Pediatric Oncology 170 Manning Dr, Chapel Hill, NC 27514 9199661178 (phone), 9199667629 (fax)
Education:
Medical School Duke University School of Medicine Graduated: 1985
Procedures:
Bone Marrow Biopsy Chemotherapy Lumbar Puncture
Conditions:
Anemia Hemolytic Anemia Hemophilia A or B Hodgkin's Lymphoma Leukemia
Languages:
English Spanish
Description:
Dr. Weston graduated from the Duke University School of Medicine in 1985. He works in Chapel Hill, NC and specializes in Pediatric Hematology-Oncology.
Us Patents
Fluorescent Sensor Compounds For Detecting Saccharides
Brent Weston - Durham NC, US Kara Hiller - Chapel Hill NC, US
International Classification:
A61K048/00 C07H021/04
US Classification:
536/023200, 514/044000
Abstract:
The present invention provides oligonucleotides that hybridizes to a nucleic acid that encodes a fucosyltransferase (FUT). The fucosyltransferase is preferably FUT3 or FUT6, along with vectors that contain the same. Pharmaceutical formulations that contain such oligonucleotides or vectors are also provided, along with methods of use thereof in the treatment of cancer.
Antisense Human Fucosyltransferase Sequences And Methods Of Use Thereof
Brent W. Weston - Durham NC Kara M. Hiller - Chapel Hill NC
Assignee:
University of North Carolina at Chapel Hill - Chapel Hill NC
International Classification:
C07H 2104
US Classification:
536 245, 4353201, 435325, 536 231
Abstract:
The present invention provides oligonucleotides that hybridizes to a nucleic acid that encodes a fucosyltransferase (FUT). The fucosyltransferase is preferably FUT3 or FUT6, along with vectors that contain the same. Pharmaceutical formulations that contain such oligonucleotides or vectors are also provided, along with methods of use thereof in the treatment of cancer.